Infectious Disease

Michael Gilmore, PhD, chairs $20 million antibiotic-resistance challenge

Michael Gilmore, PhD, chairs $20 million antibiotic-resistance challenge

April 13, 2017

In March 2017, Michael Gilmore, PhD, Director of the Harvard Infectious Disease Institute, chaired a blue ribbon panel that reviewed the most promising applications for the Antimicrobial Resistance Diagnostic Challenge--a $20 million federal prize competition to develop innovative, rapid point-of-care laboratory diagnostic tests to combat the development, and spread, of drug resistant bacteria.

michael gilmore

Mass. Eye and Ear team discovers, successfully treats new variant of antibiotic-resistant bacterium

September 15, 2016

Boston, Mass. —  Researchers at Massachusetts Eye and Ear have discovered a new mutation in a highly antibiotic-resistant strain of E. coli that resists clearance by the body’s own immune system by inhibiting white blood cells that ordinarily kill and remove bacteria.